PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Some evidence from pediatric randomized controlled trials suggests efficacy for a multicomponent product containing Grindelia robusta, Plantago lanceolata, Helichrysum italicum, and honey [PMID: 33938204].
In vitro macrophage models showed anti-inflammatory properties by reducing LPS-induced inflammatory mediators [PMID: 21031629].
Extracts displayed strong in vitro scavenging activity against oxygen and nitrogen reactive species and monoamine oxidase-A (MAO-A) inhibitory activity [PMID: 24603350].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37825252 (1881) — Grindelia Robusta in Asthma. · The Independent practitioner
- 2.PMID: 39454950 (2024) — The crystal structure of Grindelia robusta 7,13-copalyl diphosphate synthase reveals active site features controlling catalytic specificity. · The Journal of biological chemistry
- 3.PMID: 24603350 (2014) — HPLC-DAD-ESI/MS(n) analysis of phenolic compounds for quality control of Grindelia robusta Nutt. and bioactivities. · Journal of pharmaceutical and biomedical analysis
- 4.PMID: 17770060 (1984) — New crops for arid lands. · Science (New York, N.Y.)
- 5.PMID: 9691479 (1998) — Maxillary palps can mediate taste rejection of plant allelochemicals by caterpillars.